Full-Time

Customer Strategy & Success Lead

Digital Health

Updated on 9/3/2026

Evio

Evio

11-50 employees

Pharmacy solutions transforming medication experience

Compensation Overview

$170k - $210k/yr

+ Variable compensation

Remote in USA

Remote

Remote role within the United States

Category
Accounting

Get referred to Evio

See people who can refer or advise you

Requirements
  • Experience: 8+ years in roles spanning customer success, strategic account management, payer strategy, healthcare technology, consulting, implementation, or client-facing growth. You have operated in complex enterprise environments and are ready to build a function, not just manage an existing book of business.
  • Payer and Blues expertise: Deep experience working with, for, or selling into health plans. Direct experience with Blue Cross Blue Shield plans is strongly preferred; prior experience working inside a Blue or large payer is especially valuable.
  • Commercial ownership: Demonstrated ability to own or materially lead renewals, expansion, or growing existing customer relationships. You understand how to connect value realization to revenue outcomes without compromising customer trust.
  • Strategic account leadership: Proven ability to manage senior stakeholders, navigate matrixed payer organizations, run executive business reviews, and create account plans that drive action.
  • Implementation governance: Experience leading complex implementations, cross-functional launches, customer onboarding, or delivery programs where timelines, roles, risks, and customer expectations needed active management.
  • Customer success program building: Evidence of creating playbooks, customer health metrics, QBR cadences, renewal processes, expansion trackers, implementation workflows, or similar systems from scratch.
  • Team building: Experience hiring, developing, coaching, or shaping high-performing teams. You can sequence hiring needs based on customer complexity, business priorities, and operating leverage.
  • Prior experience in early-stage, scaling, or high-ambiguity environments - experience building new processes or teams in a growing, fast-paced business.
Desired Qualifications
  • Prior role inside a Blue Cross Blue Shield plan or large regional payer.
  • Experience leading customer success, client success, strategic accounts, or account management for a healthcare technology company serving payers.
  • Familiarity with pharmacy, PBM economics, specialty pharmacy, Star Ratings, quality, outcomes, real-world evidence, or payer clinical programs.
  • Experience managing renewal forecasts, account growth, or similar retention and growth metrics.
  • Consulting background with track record of growing client relationships.
  • Experience building playbooks and teams in a low-structure, high-ambiguity environment.
  • Commercially accountable: You are energized by owning retention and expansion outcomes, not just customer sentiment.
  • Customer-value obsessed: You anchor every renewal, expansion, and executive conversation in the value Evio creates for health plans and the people they serve.
  • Payer-native: You understand how health plans think, buy, prioritize, implement, and make decisions across strategy, pharmacy, clinical, quality, finance, procurement, and executive stakeholders.
  • Founder's mentality: You prototype, create, and iterate without waiting for permission or perfect infrastructure.
  • Strategic and hands on operator: You can move from executive strategy to account-level action plans, implementation milestones, customer communications, and measurable outcomes.
  • Product partner: You know how to keep Product close as a subject-matter expert while building a scalable customer success motion around them.
  • Consensus builder: You influence cross-functional stakeholders without relying on formal authority and can align teams around customer outcomes.
  • Resilient & pragmatic: You are comfortable with ambiguity, escalation, and imperfect information, and you choose practical, high-leverage solutions over perfection.
  • Exceptional communicator: You can communicate crisply with payer executives, internal leaders, product experts, and early-career team members.

Evio partners with health plans to improve access to medications for patients, providers, and the health system by using real-world evidence to ensure the right medication is prescribed and affordable. It works by aligning data, care teams, and benefit design within payer and provider workflows to streamline the medication journey. Compared to competitors, Evio ties real-world data to payer and provider processes and emphasizes affordability and appropriate prescribing across the medication continuum. Its goal is to make the medication experience safer, easier to navigate, and cheaper while reducing waste in healthcare.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

Costa Mesa, California

Founded

2011

Get referred to Evio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Wellmark's March 2025 investment validates Evio's model and expands Midwestern payer distribution.
  • Fresenius Kabi's October 2024 adalimumab deal gave Evio a visible biosimilar win.
  • Evio's August 2026 website still promotes Evio Access, showing continued manufacturer selling.

What critics are saying

  • Evio depends on six Blue plan owners; one defection would crush negotiating leverage.
  • PBMs like CVS Caremark and OptumRx can outbid Evio with broader formulary control.
  • No public 2026 revenue, customer, or hiring disclosure limits investor visibility.

What makes Evio unique

  • Evio Access launched February 25, 2025, bundles contracting, RWE, and pull-through services.
  • Wellmark joined March 6, 2025, expanding Evio to six Blue plan owners.
  • Evio analyzes over 1 billion claims across 35 million lives, powering non-PBM contracting.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401K Company Match

Unlimited Paid Time Off

Parental Leave

Company News

PR Newswire
Mar 6th, 2025
Evio Pharmacy Solutions Announces Wellmark As Its Newest Health Plan Investor In Effort To Address High-Cost Medications

DENVER, March 6, 2025 /PRNewswire/ -- Evio Pharmacy Solutions proudly announces the addition of Wellmark Blue Cross and Blue Shield as its sixth investor and owner health plan. This new partnership is an exciting development for Evio as the company welcomes its first new investor since its establishment four years ago.Wellmark, a member-owned independent licensee of the Blue Cross Blue Shield Association, serves more than two million people in Iowa and South Dakota. Wellmark, known for its innovative approaches and commitment to making health care better, will further Evio's mission to deliver differentiated pharmacy care.Evio works with health plans to transform the medication experience for everyone: patients, providers, employers, and the pharmacy system at large. Utilizing real-world evidence analytics, innovative medication contracting models, and a suite of digital tools, Evio aims to ensure every patient can access the right medication for their unique situation, from the beginning, in a simple and affordable way."Our board and I are thrilled to welcome Wellmark to help drive our transformative agenda," said Hank Schlissberg, chief executive officer of Evio. "Having established a compelling vision, a phenomenal team, and a track record of measurable impact, Evio was open to new partners for the first time. When we evaluated potential additions, Wellmark quickly rose to the top

Fierce Healthcare
Oct 2nd, 2024
Blue Shield of California inks deal to buy Humira biosimilar directly from manufacturer

Blue Shield is teaming up with drugmaker Fresenius Kabi and Evio Pharmacy Solutions to purchase a biosimilar for Humira at a transparent net price of $525 per monthly dose.

pharmaphorum
Oct 2nd, 2024
Blue Shield of California bypasses PBMs to slash Humira prices by 90%

Blue Shield's agreement with drug manufacturer Fresenius Kabi, an operating company of Fresenius, and Evio Pharmacy Solutions, which facilitated the deal, introduces a new model called Pharmacy Care Reimagined.

PR Newswire
Oct 1st, 2024
Evio Announces Groundbreaking Direct Purchase Agreement For Adalimumab Biosimilar

DENVER, Oct. 1, 2024 /PRNewswire/ -- Evio Pharmacy Solutions, a Blues-founded company focused on transformational solutions in the high-cost medication space, today announced the successful negotiation and implementation of an innovative direct purchase agreement with Fresenius Kabi, an operating company of Fresenius, for Adalimumab-aacf — a lower priced biosimilar version of Humira. Humira is one of the most widely prescribed and, at more than $12 billion annually, the highest revenue producing medication in the United States. This landmark direct purchase agreement creates a transparent, alternative business model that makes a highly effective treatment accessible to Evio owner health plans and their members at a lower cost. Biosimilars are low-cost biologic medications highly similar to an already approved reference product. They have been rigorously tested and have demonstrated the same clinical benefit and safety as the original product

dBusiness
Jan 25th, 2023
Evio Pharmacy Solutions, Part of BCBS Michigan, Partners to Boost Price Transparency

To increase price transparency, Evio Pharmacy Solutions, part of BCBS Michigan, has partnered with Flipt.